# hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure

> **NCT00008801** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Diabetes Mellitus, Insulin-Dependent
- Diabetes Mellitus, Experimental
- Transplantation, Homologous
- Islets of Langerhans Transplantation

## Interventions

- **DRUG:** hOKT3gamma1 (Ala-ala)

## Key facts

- **NCT ID:** NCT00008801
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008801, "hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00008801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*